BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MedNet - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MedNet
X-ORIGINAL-URL:https://mednetus.net
X-WR-CALDESC:Events for MedNet
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221130
DTEND;VALUE=DATE:20221201
DTSTAMP:20260424T121344
CREATED:20250620T075835Z
LAST-MODIFIED:20250620T075835Z
UID:10000020-1669766400-1669852799@mednetus.net
SUMMARY:New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases - Live Event
DESCRIPTION:November 30\, 2022 \n\n\nTake Me to the Event Registration\n\n\nEVENT Summary \nDates \nWednesday\, November 30\, 2022\, 7:00 PM EDT \nLocation \nVirtual \nTarget Audience \nGastroenterologists\, internal medicine specialists\, primary care physicians\, nurse practitioners\, physician assistants\, and nurses caring for patients with inflammatory bowel diseases (IBDs) \nFormat \nLive Webinar \nCredits \n1.25 / AMA PRA Category 1 Credit(s)TM\n1.25 / ANCC Contact Hours \nCost \nFree \nProgram Description \nClick to Go to the Event Registration \nInflammatory bowel diseases (IBD)\, commonly categorized as Crohn’s disease (CD) and ulcerative colitis (UC)\, are immune mediated chronic inflammatory disorders of the gastrointestinal tract. The etiopathogenesis is multifactorial\, with different environmental\, genetic\, immune mediated\, and gut microbial factors playing an important role. The current therapy goals are to improve clinical symptoms\, control inflammation\, prevent complications\, and improve quality of life. Different therapeutic agents are available with their indications\, mechanisms of action\, and side effects. The field of IBD therapeutics has seen tremendous improvements\, and the efficacy of new drug targets such as IL-12/IL-23\, the JAK/STAT pathway\, and S1P has been established. \nAgenda \n\nRole of the drug targets such as S1P\, the JAK/STAT\, the IL-12/IL-23 pathway\, and biosimilars in managing IBD – Miguel Regueiro\, MD\nCase Presentation 1 – Miguel Regueiro\, MD\nDiscuss the interdisciplinary management of extra-intestinal manifestations in people living with IBD – Francis Farraye\, MD\nCase Presentation 2 – Farraye\, MD\nQ&A from the Audience and Panel Discussion – Miguel Regueiro\, MD/Francis Farraye\, MD\n\nIntended Audience \nGastroenterologists\, internal medicine specialists\, primary care physicians\, nurse practitioners\, physician assistants\, and nurses caring for patients with inflammatory bowel diseases (IBDs). \nCommercial Supporters \nSupported by educational grants from Pfizer Inc. and Bristol Myers Squibb. \nLearning Objectives \n\nIncorporate biologics\, small molecule inhibitors\, and biosimilars in the treatment of inflammatory bowel diseases (IBD)\nAssess the interdisciplinary management strategies of extra-intestinal manifestations in people living with IBD\n\nAccredited Providers \nJointly provided by Amedco\, a CME/CE company\, and MedNet \n       \nJoint Accreditation \n \nIn support of improving patient care\, this activity has been planned and implemented by Amedco LLC and MEDNET. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, to provide continuing education for the healthcare team. \nPhysicians (ACCME) Credit \nDesignation Statement \nAmedco LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nNurses (ANCC) Credit \nDesignation Statement \nAmedco LLC designates this activity for a maximum of 1.25 ANCC contact hours. \nAdditional Credit Information \nNurse Practitioners\nThe American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 1.25 hours. \nPhysician Assistants\nAAPA accepts AMA PRA Category 1 Credit(s)TM for the PRA from organizations accredited by ACCME. Maximum of 1.25 hours. \nStaff Disclosures \nThe planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: \n\nKamatham A. Naidu\, PhD (MedNet) has no relevant financial relationships.\nBrian Waggoner (MedNet) has no relevant financial relationships to disclose.\nSheryl Morgan (Amedco) has no relevant financial relationships to disclose.\n\nFaculty \n \nMiguel Regueiro\, MD\nProfessor\, Department of Medicine\nChair\, Digestive Disease and Surgery Institute\nChair\, Department of Gastroenterology\, Hepatology\, and Nutrition\nThe Pier C. and Renee A. Borra Family Endowed Chair in Gastroenterology and Hepatology\nCleveland Clinic Lerner College of Medicine of Case Western Reserve University\nCleveland\, OH \n \nFrancis Farraye\, MD\nProfessor of Medicine\nDirector\, Inflammatory Bowel Disease Center\nDivision of Gastroenterology and Hepatology\nMayo Clinic\nJacksonville\, Florida \nInstructions/Technical Requirements \n\nA desktop or laptop computer with a stable internet connection and audio capability is required to attend. Joining via mobile or tablet is possible but not recommended.\nTimes in the portal adjust to your computer; however\, some browsers have a separate time zone adjustment.\nFor the best viewing experience\, we recommend the following browsers: Chrome\, Firefox\, and Safari. For attendees viewing on Internet Explorer 11\, you may experience lags in streaming. To maximize your attendee hub experience\, we recommend you not sign in through your company assigned VPN.\nEnsure that your computer’s sound is enabled for your browser and allow permissions to the On24 Attendee Hub platform if necessary.\n\nCost \nComplimentary \nContact \nBrian Waggoner\nProgram Manager\nMedNet\nbrianw@mmhus.net
URL:https://mednetus.net/event/new-paradigms-in-the-clinical-practice-of-inflammatory-bowel-diseases-live-event/
CATEGORIES:Live Program
ATTACH;FMTTYPE=image/jpeg:https://mednetus.net/wp-content/uploads/2025/06/az67bbjmkb29-Oveview800x450.jpg
END:VEVENT
END:VCALENDAR